Weird But Effective Stock: MYOS Corporation common stock (NASDAQ: MYOS)
On Thursday, MYOS Corporation common stock (NASDAQ: MYOS) started its trading session with the price $1.61 and closed at price of $1.56 by scoring -2.5%. Day range of the stock was $1.56 – $1.62. MYOS stock traded with total volume of 11876 shares while the average trading capacity remained 4772 shares. Earnings per share was $-0.45. MYOS has total market capitalization of $14306759.
MYOS RENS Technology Inc. (MYOS) recently reported its financial results for the three and nine months ended September 30, 2019.
Third Quarter – Three Months Ended September 30, 2019:
- Net revenues increased $284, or 430%, to $350 contrast to net revenues of $66 for the three months ended September 30, 2018.
- Gross profit for the three months ended September 30, 2019 increased $169 or 2,414% to $176, contrast to $7 for the three months ended September 30, 2018.
- Operating expenses for the three months ended September 30, 2019 increased $171 or 18% to $1,087 contrast to $916 for the three months ended September 30, 2018.
- Net loss increased $10 or 1% to $921 for the three months ended September 30, 2019 contrast to $911 for the three months ended September 30, 2018.
Nine Months Ended September 30, 2019:
- Net revenues for the nine months ended September 30, 2019 increased $442 or 209% to $653 contrast to net revenues of $211 for the nine months ended September 30, 2018.
- Gross profit for the nine months ended September 30, 2019 increased $276 or 452% to $337, contrast to $61 for the nine months ended September 30, 2018.
- Operating expenses for the nine months ended September 30, 2019 increased $161 or 5% to $3,377, contrast to $3,216 for the nine months ended September 30, 2018.
- Net loss reduced 3% to $3,071 for the nine months ended September 30, 2019 contrast to $3,158 for the nine months ended September 30, 2018.
Management Commentary:
Joseph Mannello, Chief Executive Officer of MYOS, commented, “We are very happy with our strong financial results for the third quarter 2019, with revenues during this quarter exceeding our revenues during the first half of 2019. As stated in previous communications, we are extremely focused on growing sales for our two key products, Myos Canine Muscle Formula® and Yolked®. Our various commercial initiatives are focused on increasing Fortetropin’s reach and presence, and growing our revenues substantially.
“We are extremely encouraged by the promising results from multiple human and canine clinical studies to date and are delighted to work with the respected research group of Professor Phillips at McMaster University. Completing this study is an important part of our commercial strategy to increase our business in this growing market of tremendous prospects .
“Moving forward, we expect continued growth in our veterinary section as the positive results from our clinical study at Kansas State University become more widely known, which will be supported by an aggressive marketing campaign.
“We are truly excited about the course ahead for the remainder of 2019 and beyond. We firmly believe that this quarter has been a major turning point for our company and that the future looks exceedingly positive. We believe that we are well positioned to drive future growth in multiple market sections, which will enable us to build upon our business and deliver value for our shareholders,” concluded Mr. Mannello.
MYOS is recorded at 0.08 and the relative strength index of the stock stands 61.56. A look on the firm performance, its monthly performance is 12.86% and a quarterly performance of -3.66%. The stock price is trading upbeat from its 200 days moving average with 5.70% and up from 50 days moving average with 7.59%.
Vivian Moore – Health and Biotech
I am Vivian Moore, I have done my bachelor’s in English literature, and further on I did my master’s in Medicines. My most preferred genre of writing is health and biotech. I have been writing from the past 6 years about articles, web content, and blogs. In my career and education, I like to play along with work. I have also been a teacher in the past for 2 years. I use to teach business and technical writing in a very famous university. However, most recently I am working as an instructor, designer, and training writer. I enjoy socializing a lot. I am a very big extrovert when it comes to nature. A part of all this I enjoy exploring the world and traveling makes me happy.
